Cargando…

Current Status of Oligonucleotide-Based Protein Degraders

Transcription factors (TFs) and RNA-binding proteins (RBPs) have long been considered undruggable, mainly because they lack ligand-binding sites and are equipped with flat and narrow protein surfaces. Protein-specific oligonucleotides have been harnessed to target these proteins with some satisfacto...

Descripción completa

Detalles Bibliográficos
Autores principales: Shih, Po-Chang, Naganuma, Miyako, Demizu, Yosuke, Naito, Mikihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055846/
https://www.ncbi.nlm.nih.gov/pubmed/36986626
http://dx.doi.org/10.3390/pharmaceutics15030765
_version_ 1785015974457507840
author Shih, Po-Chang
Naganuma, Miyako
Demizu, Yosuke
Naito, Mikihiko
author_facet Shih, Po-Chang
Naganuma, Miyako
Demizu, Yosuke
Naito, Mikihiko
author_sort Shih, Po-Chang
collection PubMed
description Transcription factors (TFs) and RNA-binding proteins (RBPs) have long been considered undruggable, mainly because they lack ligand-binding sites and are equipped with flat and narrow protein surfaces. Protein-specific oligonucleotides have been harnessed to target these proteins with some satisfactory preclinical results. The emerging proteolysis-targeting chimera (PROTAC) technology is no exception, utilizing protein-specific oligonucleotides as warheads to target TFs and RBPs. In addition, proteolysis by proteases is another type of protein degradation. In this review article, we discuss the current status of oligonucleotide-based protein degraders that are dependent either on the ubiquitin–proteasome system or a protease, providing a reference for the future development of degraders.
format Online
Article
Text
id pubmed-10055846
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100558462023-03-30 Current Status of Oligonucleotide-Based Protein Degraders Shih, Po-Chang Naganuma, Miyako Demizu, Yosuke Naito, Mikihiko Pharmaceutics Review Transcription factors (TFs) and RNA-binding proteins (RBPs) have long been considered undruggable, mainly because they lack ligand-binding sites and are equipped with flat and narrow protein surfaces. Protein-specific oligonucleotides have been harnessed to target these proteins with some satisfactory preclinical results. The emerging proteolysis-targeting chimera (PROTAC) technology is no exception, utilizing protein-specific oligonucleotides as warheads to target TFs and RBPs. In addition, proteolysis by proteases is another type of protein degradation. In this review article, we discuss the current status of oligonucleotide-based protein degraders that are dependent either on the ubiquitin–proteasome system or a protease, providing a reference for the future development of degraders. MDPI 2023-02-24 /pmc/articles/PMC10055846/ /pubmed/36986626 http://dx.doi.org/10.3390/pharmaceutics15030765 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Shih, Po-Chang
Naganuma, Miyako
Demizu, Yosuke
Naito, Mikihiko
Current Status of Oligonucleotide-Based Protein Degraders
title Current Status of Oligonucleotide-Based Protein Degraders
title_full Current Status of Oligonucleotide-Based Protein Degraders
title_fullStr Current Status of Oligonucleotide-Based Protein Degraders
title_full_unstemmed Current Status of Oligonucleotide-Based Protein Degraders
title_short Current Status of Oligonucleotide-Based Protein Degraders
title_sort current status of oligonucleotide-based protein degraders
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055846/
https://www.ncbi.nlm.nih.gov/pubmed/36986626
http://dx.doi.org/10.3390/pharmaceutics15030765
work_keys_str_mv AT shihpochang currentstatusofoligonucleotidebasedproteindegraders
AT naganumamiyako currentstatusofoligonucleotidebasedproteindegraders
AT demizuyosuke currentstatusofoligonucleotidebasedproteindegraders
AT naitomikihiko currentstatusofoligonucleotidebasedproteindegraders